Press release
Generic Drugs Market Growth Driven by Patent Expirations and Cost-Effective Healthcare Demand 2025-2033 | Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Lupin Limited
Generic Drugs Market
Generic Drugs Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory frameworks, the report delivers strategic insights to support stakeholders in navigating the rapidly advancing sector from 2025 to 2033.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/generic-drugs-market?ophp
Generic drugs are bioequivalent versions of branded medications that offer the same dosage, safety, strength, and efficacy at a lower cost. The market is growing steadily as healthcare systems prioritize cost containment, patent expirations open opportunities for new entries, and regulatory support accelerates approvals to ensure broad access to essential medicines.
Generic Drugs Market Competitors Overview:
Teva Pharmaceutical Industries Ltd., Sandoz (a Novartis Division), Viatris Inc., Sun Pharmaceutical Industries Ltd, Lupin Limited, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Zydus Lifesciences Ltd, Fresenius Kabi AG, and Amneal Pharmaceuticals Inc., among others.
Important Industry Updates of 2023, 2024 and 2025:
✅In February 2025, Glenmark Pharmaceuticals launched Latanoprost ophthalmic solution, a 0.005% (0.05mg/mL) generic medication to treat glaucoma in the US market, which is therapeutically equivalent to Upjohn US LLC's reference-listed drug, Xalatan Ophthalmic Solution. The Mumbai-based drug maker announced the launch.
✅In November 2024, Sunshine Biopharma, a Canadian pharmaceutical company, launched a new generic prescription drug through its subsidiary, Nora Pharma Inc., which specializes in life-saving medicines in oncology and antivirals.
Methodology and Scope
The Generic Drugs Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/generic-drugs-market?ophp
Generic Drugs Market Segments Overview:
∎ By Product (Cardiovascular Drugs, Oncology Drugs, Respiratory Drugs, Gastrointestinal Drugs, Neurology Drugs, Others)
∎ By Route of Administration (Oral, Injectable, Topical, Others)
∎ By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Regional Overview for Generic Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=generic-drugs-market?ophp
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the «Keyword» market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the «Keyword» market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Drugs Market Growth Driven by Patent Expirations and Cost-Effective Healthcare Demand 2025-2033 | Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Lupin Limited here
News-ID: 4106363 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Biologics Contract Manufacturing Market Accelerates with Growing B …
Outsourced biologics manufacturing including monoclonal antibodies (mAbs), vaccines, and advanced therapies such as cell and gene treatments has become essential to driving biopharma innovation. According to DataM Intelligence, the global biologics contract manufacturing market was valued at USD 26.03 billion in 2024 and is projected to reach USD 83.47 billion by 2033, expanding at a CAGR of 14.0% between 2025 and 2033.
Download exclusive insights with our detailed sample report (Corporate…
United States Healthcare Data Monetization Market Fueled by Growing Demand for R …
Healthcare data monetization involves transforming patient, claims, EHR, genomic and device-generated information into actionable insights and services. Based on DataM Intelligence analysis, the market was valued at approximately USD 0.6 billion in 2024 and is projected to reach USD 1.35 billion by 2031, reflecting a compound annual growth rate (CAGR) of 19.2%.
The accelerating adoption of artificial intelligence, real-world evidence generation, and cloud analytics platforms are key drivers behind this rapid…
Plant-Based Meat Market 2025 | Growth Drivers, Key Players & Investment Opportun …
Market Size and Growth
Global Plant-based Meat Market reached USD 5.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 21.7 billion by 2031. The market is expected to exhibit a CAGR of 20.2% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In July 2025, Impossible Foods launched grilled plant-based chicken strips nationwide, expanding its product line to cater to the growing demand…
United States Detox Drinks Market Outlook | Market Drivers, Innovation & Investo …
Market Size and Growth
Global Detox Drinks Market is expected to exhibit a CAGR of 6.52% during the forecast period (2024-2031).
Key Development:
United States:
✅ In August 2025, PepsiCo launched its Prebiotic Cola, a soda with 30 calories, no artificial sweeteners, and three grams of prebiotic fiber. This move reflects the company's response to the growing demand for functional beverages.
✅ In May 2025, PepsiCo acquired prebiotic soda company Poppi for $1.95 billion,…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
